LeuHJ. Differential diagnosis of chronic leg ulcers. Angiology1963;14:288–96.
2.
HinesEAJr. The differential diagnosis of chronic ulcer of the leg. Circulation1963;27:989–96.
3.
MateoJOliverABorrellM. Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism—results of the Spanish Multicentric Study on Thrombophilia (EMET-Study). Thromb Haemost1997;77:444–51.
4.
MackenzieRKLudlamCARuckleyCV. The prevalence of thrombophilia in patients with chronic venous leg ulceration. J Vasc Surg2002;35:718–22.
5.
MartinelliIMannucciPMDe StefanoV. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: A study of 150 families. Blood1998;92:2353–8.
6.
MaherCCrowleyDCullenC. Double fluorescent-amplification refractory mutation detection (dF-ARMS) of the factor V Leiden and prothrombin mutations. Thromb Haemost1999;81:76–80.
7.
BertinaRMKoelemanBPKosterT. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature1994;369(6475):64–7.
8.
GaberYSiemensHJSchmellerW. Resistance to activated protein C due to factor V Leiden mutation: High prevalence in patients with post-thrombotic leg ulcers. Br J Dermatol2001;144:546–8.
9.
Maessen-VischMBHamulyakKTazelaarDJ. The prevalence of factor V Leiden mutation in patients with leg ulcers and venous insufficiency. Arch Dermatol1999;135:41–4.
10.
HackenjosKBekMSchopfEVanscheidtW. Recurrent ulcerations on both legs since early childhood due to a factor V gene mutation. Dermatology1997;194:297–8.
11.
LaneDAMannucciPMBauerKA. Inherited thrombophilia: Part 1. Thromb Haemost1996; 76:651–62.
12.
FosterDCYoshitakeSDavieEW. The nucleotide sequence of the gene for human protein C. Proc Natl Acad Sci USA1985;82:4673–7.
13.
ReitsmaPH. Protein C deficiency: From gene defects to disease. Thromb Haemost1997;78:344–50.
14.
FalangaVBontempoFAEaglsteinWH. Protein C and protein S plasma levels in patients with lipodermatosclerosis and venous ulceration. Arch Dermatol1990;126:1195–7.
15.
RezendeSMSimmondsRELaneDA. Coagulation, inflammation, and apoptosis: Different roles for protein S and the protein S-C4b binding protein complex. Blood2004;103:1192–201. Epub 2003 Aug 7.
16.
CompPCNixonRRCooperMREsmonCT. Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest1984;74:2082–8.
17.
EngesserLBroekmansAWBrietE. Hereditary protein S deficiency: Clinical manifestations. Ann Intern Med1987;106:677–82.
18.
PetersenEJAllaartRCMeuwissenOJ. A Dutch family with hereditary protein S deficiency. Netherlands J Med1989;34:243–50.
19.
TsutsuiKIshidaWOhashiTTakeharaK. Hereditary type IIb protein S deficiency in a patient with recurrent venous ulcers. Dermatology1997;194:198–9.
20.
KulthananKKrudumTPintaditP. Chronic leg ulcers associated with hereditary protein S deficiency. Int J Dermatol1997;36:210–2.
21.
DillmonMSSaagMSHamzaSH. Unusual thromboses associated with protein S deficiency in patients with acquired immunodeficiency syndrome: Case reports and review of the literature. AIDS Res Hum Retroviruses2005;21:753–6.
22.
ZollerBHeXDahlbackB. Homozygous APC-resistance combined with inherited type I protein S deficiency in a young boy with severe thrombotic disease. Thromb Haemost1995;73:743–5.
23.
ZhouAHuntingtonJACarrellRW. Formation of the antithrombin heterodimer in vivo and the onset of thrombosis. Blood1999;94:3388–96.
24.
PerryDJ. Antithrombin and its inherited deficiencies. Blood Rev1994;8:37–55.
25.
Pereira de GodoyJMAndrade TorresCABraileDM. Prevalence of antithrombin deficiency in patients with chronic leg ulcer. Blood Coagul Fibrinolysis2001;12:593–5.
26.
CosgriffTMBishopDTHershgoldEJ. Familial antithrombin III deficiency: Its natural history, genetics, diagnosis and treatment. Medicine (Baltimore)1983;62:209.
27.
DevineDVKinneyTRThomasPF. Fragment D-dimer levels: An objective marker of vaso-occlusive crisis and other complications of sickle cell disease. Blood1986;68:317–9.
28.
AndrejevicSBonaci-NikolicBBukilicaM. Purpura and leg ulcers in a patient with cryoglobulinaemia, non-Hodgkin's lymphoma, and antiphospholipid syndrome. Clin Exp Dermatol2003;28:151–3.
29.
FucharoenSKetvichitPPootrakulP. Clinical manifestation of beta-thalassemia/hemoglobin E disease. J Pediatr Hematol Oncol2000;22:552–7.
30.
Krupa ShankarDSAkhibS. Leg ulcers due to hyperhomocysteinemia. Indian J Dermatol Venereol Leprol2006;72:367–9.
31.
SchvedJFDupuy-FonsCBironC. A prospective epidemiological study on the occurrence of antiphospholipid antibody: The Montpellier Antiphospholipid (MAP) Study. Haemostasis1994;24:175–82.
32.
GiraldiSAbbageKTMarinoniLP. Leg ulcer in hereditary spherocytosis. Pediatr Dermatol2003; 20:427–8.
33.
HerouyYHellsternMOVanscheidtW. Factor XIII-mediated inhibition of fibrinolysis and venous leg ulcers. Lancet2000;355(9219):1970–1.
34.
FinkAMKottas-HeldenbergABayerPM. Lupus anticoagulant in patients with chronic venous insufficiency. Acta Derm Venereol2003;83:287–9.
35.
Sulaiman-ShoabS. Activated protein C resistance: The commonest hereditary hypercoagulation disorder. Br J Surg1998;85:1161.
36.
BanerjeeDGreyJHardingKG. An unusual cause of leg ulceration. Postgrad Med J1999;75:247–8.
37.
BaglinT. Management of thrombophilia: Who to screen?Pathophysiol Haemost Thromb2003/2004;33:401–4.
38.
JordaanDJSchoonMGBadenhorstPN. Thrombophilia screening in pregnancy. Obstet Gynecol Surv2005;60:394–404.
39.
PeusDHeitJAPittelkowMR. Activated protein C resistance caused by factor V gene mutation: Common coagulation defect in chronic venous leg ulcers?J Am Acad Dermatol1997;36:616–20.
40.
PeusDvon SchmiedebergSPierA. Coagulation factor V gene mutation associated with activated protein C resistance leading to recurrent thrombosis, leg ulcers, and lymphedema: Successful treatment with intermittent compression. J Am Acad Dermatol1996;35(2 Pt 2):306–9.
